Elite Diagnostic Limited (JMSE:ELITE)
Jamaica · Delayed Price · Currency is JMD 1.510
0.00 (0.00%)
At close: Mar 10, 2025
Ligand Pharmaceuticals Market Cap
Elite Diagnostic has a market cap or net worth of 533.63 million as of August 5, 2025. Its market cap has decreased by -11.18% in one year.
Market Cap
533.63M
Enterprise Value
906.79M
Revenue
873.00M
Ranking
n/a
PE Ratio
14.53
Stock Price
$1.51
Market Cap Chart
Since June 19, 2018, Elite Diagnostic's market cap has decreased from 1.10B to 533.63M, a decrease of -51.29%. That is a compound annual growth rate of -10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2025 | 533.63M | -20.53% |
| Dec 31, 2024 | 671.46M | 11.76% |
| Dec 29, 2023 | 600.78M | -46.03% |
| Dec 30, 2022 | 1.11B | 10.53% |
| Dec 31, 2021 | 1.01B | -5.00% |
| Dec 31, 2020 | 1.06B | -39.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scotia Group Jamaica | 168.02B |
| Sagicor Group Jamaica | 164.04B |
| Barita Investments | 84.02B |
| Pan Jamaica Group | 83.01B |
| Wisynco Group | 80.33B |
| Carreras | 79.42B |
| Caribbean Cement Company | 78.09B |
| Seprod | 76.01B |